Skip to main content
Equibles
QTRX logo

QTRX · Quanterix Corp · Metrics

Track QTRX — free

Use QTRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research QTRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.56 +0.06 (+2.40%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$121.07M
Shares
47.29M

QTRX metrics

67 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.56
Market cap
$121.07M

Price action

20 metrics
Price change (1W)
-4.8%
Price change (30D)
-1.2%
Price change (3M)
-17.4%
Price change (6M)
-45.8%
Price change (YTD)
-59.7%
Price change (1Y)
-46.6%
Trailing year
Price change (5Y)
-94.7%
52-week high
$8.06
52-week low
$2.42
Change from 52-week high
-68.2%
Change from 52-week low
+5.8%
Annualized volatility
90.2%
Annualized volatility (3M)
124.5%
Beta
2.1
RSI (14D)
41.2
Price vs SMA 50
-22.6%
Price vs SMA 200
-43.8%
Avg volume (3M)
813,692
Relative volume
0.4
Average dollar volume
$2.73M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
47.29M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.8×
reciprocal yield 126.7%
P / book
0.5
reciprocal yield 195.9%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-101.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
12.1×
reciprocal yield 8.3%
EV / revenue historical average (5Y)
12.1×
reciprocal yield 8.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-10

Profitability

9 metrics
Gross margin
44.6%
Operating margin
-99.6%
Trailing 12 months
Net margin
-80.2%
Gross profit (TTM)
$68.36M
Operating profit (TTM)
−$152.87M
Net income (TTM)
−$123.11M
Trailing 12 months
Diluted EPS (TTM)
$-2.62
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$6.33

Growth

11 metrics
Revenue growth YoY
+34.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$153.41M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+21.3%
Year over year · more shares
Revenue CAGR (3Y)
+9.6%
Revenue CAGR (5Y)
+10.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-51.9%
Return on assets
-38.5%
Debt / equity
—
Current ratio
3.4
EBITDA (TTM)
−$129.47M
Free cash flow (TTM)
—
Quick ratio
2.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$44.17M
Total assets
$319.63M
Total debt
$3.94M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$80.92M
Capital expenditures (TTM)
$762,000
R&D (TTM)
$31.95M
SG&A (TTM)
$133.61M
Stock compensation (TTM)
$18.62M
R&D / revenue
20.8%
Stock compensation / revenue
12.1%

Ownership (13F)

3 metrics
13F filers
133
13F filer change QoQ
+5
Institutional ownership
62.8%

Short interest

3 metrics
Short interest
10.2%
Latest settlement · 8.3 days to cover
Days to cover
8.3d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
$286,354
Insider-sentiment score
85 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1503274 CUSIP 74766Q101 13F (30d) 46 filings 46 filers Visit website Investor relations